| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Oramed Pharmaceuticals (NASDAQ:ORMP) through any online brokerage.
Other companies in Oramed Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
There is no analysis for Oramed Pharmaceuticals to provide a consensus price target.
The stock price for Oramed Pharmaceuticals (NASDAQ: ORMP) is $4.12 last updated October 22, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Oramed Pharmaceuticals.
Oramed Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Oramed Pharmaceuticals.
Oramed Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
